Source MDx Announces 16 Molecular Diagnostic Development Programs Will Be Offered for Sale on April 29, 2011
3/29/2011 9:59:12 AM
More...
|
Source MDx Announces Foundational Patents Will Be Offered for Sale on April 29, 2011
3/22/2011 9:22:54 AM
More...
|
Dana-Farber Cancer Institute Oncologists Present Results of Source MDx's RNA Transcript-Based Six-Gene Test to Predict Survival of Castration-Resistant Prostate Cancer Patients at GU ASCO Symposium
2/27/2009 9:50:42 AM
More...
|
Source MDx Announces Partnership With Brigham and Women's Hospital to Study RNA-Based Biomarkers for Multiple Sclerosis
11/3/2008 9:12:29 AM
More...
|
XDx, Inc. Files Reexamination Request for Source MDxPatent
2/15/2008 9:13:40 AM
More...
|
Source MDx Announces Translational Molecular Medicine Collaboration With Pfizer Inc. (PFE)
12/27/2007 8:41:49 AM
More...
|
Source MDx to Participate in Breakout Session Focused on Companion Diagnostics at the 2007 Biotechnology Industry Organization (BIO) International Convention
5/3/2007 3:42:40 PM
More...
|
Tufts-New England Medical Center And Source MDx Will Collaborate To Investigate The Clinical Use Of RNA-based Biomarkers To Monitor RA Disease Status And Response To Therapy
11/9/2006 11:12:34 AM
More...
|
Source MDx Launches OncoProfiling(SM) Biomarker Services For Targeted Oncology Drug Development
9/15/2006 11:10:22 AM
More...
|
University of Colorado At Denver And Health Sciences Center And Source MDx Form Research Collaboration To Develop Molecular Diagnostics For Melanoma And Psoriasis
6/1/2006 12:23:26 PM
More...
|
|